Congress funds maternal health research targeting disparities in high-mortality communities
S. 3254 — NIH IMPROVE Act · Filed by Katie Britt (R-AL) · 4 cosponsors · Introduced Nov 20, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill formally establishes the IMPROVE Initiative within the National Institutes of Health, a research program focused on reducing maternal mortality and severe maternal morbidity, with particular emphasis on health disparities affecting women with disproportionately high maternal death rates. The NIH Director is authorized to award grants and contracts to fund research into preventable causes of maternal death, community-based interventions, and underlying biological mechanisms, with $73.4 million authorized annually from 2026 through 2031.
Why we flagged it
The bill is a straightforward authorization of federal research funding for maternal health outcomes, with no private carve-outs, tax provisions, or regulatory changes. It is a standard public-health appropriations measure.
What the text implies
- The bill's focus on 'health disparities' and 'disproportionately affected women' may drive research funding toward rural, low-income, and communities of color with elevated maternal mortality — a geographic and demographic reallocation of NIH research dollars that could shift institutional research priorities.
- Authorization of $73.4M annually through 2031 creates a multi-year funding stream that, if appropriated, will compete with other NIH priorities; actual impact depends on whether Congress appropriates the full authorized amount or treats it as a cap.
Who stands to gain
academic medical centers and research universities (grant recipients); community health organizations (contract awardees for interventions); NIH-funded research institutions